AMSTERDAM (AP) — European regulator says benefits of Johnson & Johnson vaccine outweigh risks despite ‘possible link” to rare blood clots.
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.